Paul Baldrick

Paul Baldrick

Company: Labcorp Oncology

Job title: Executive Director, Nonclinical Regulatory Strategy, Product Development and Market Access Consulting

Bio:

Paul Baldrick is Executive Director, Nonclinical Regulatory Strategy within the Global Regulatory Affairs Department at Covance and is based in Harrogate in the UK; he has a BSc (1983) and PhD (1988) from Durham University, UK. Professor Baldrick is also Visiting Chair (Regulatory Toxicology) of the Lincoln School of Pharmacy, College of Science, University of Lincoln. His main responsibilities include providing regulatory strategy/preclinical support for new product development and registration of small molecule pharmaceuticals, biotechnology products, gene and cell therapy products, vaccines and medical devices. Professor Baldrick joined Covance in 1998 and has over 30 years of experience in preclinical development (CRO, UK and Belgium industry) with knowledge of the development of many compound classes and regulatory issues/submissions; he has written numerous peer-reviewed publications (over 60) and book reviews and is a regular podium speaker/chairperson as well as a lecturer on training courses for a range of preclinical topics. He is a Registered Toxicologist and a Fellow of The British Toxicology Society (FBTS). He is also Associate Editor for Toxicology Reports and on the editorial board of Journal of Toxicology.

Seminars:

Q&A 11:00 am

You can take part in this interactive Q&A by submitting questions via the live chat tabRead more

day: Agenda: Risks, Dead-ends & Avoidable Delays: Optimising Preclinical Planning & Biomarker Targets to Maximise Clinical Development in Precision & Immuno-Oncology

Q&A 11:10 am

You can take part in this interactive Q&A by submitting questions via the live chat tabRead more

day: Labcorp Oncology Engager - Agenda

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.